Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and prior treatment. Receptors of oncolytic herpes simpl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Oncolytics
Main Authors: Ghose, Jayeeta, Dona, Ada, Murtadha, Mariam, Gunes, Emine Gulsen, Caserta, Enrico, Yoo, Ji Young, Russell, Luke, Jaime-Ramirez, Alena Cristina, Barwick, Benjamin G., Gupta, Vikas A., Sanchez, James F., Sborov, Douglas W., Rosen, Steven T., Krishnan, Amrita, Boise, Lawrence H., Kaur, Balveen, Hofmeister, Craig C., Pichiorri, Flavia
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Gene & Cell Therapy 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940704/
https://ncbi.nlm.nih.gov/pubmed/33738338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares